Immediate Impact
54 standout
Citing Papers
Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2025 Standout
GPCR drug discovery: new agents, targets and indications
2025 Standout
Works of Min Guo being referenced
The Value of Targeting CXCR4 With 68Ga-Pentixafor PET/CT for Subtyping Primary Aldosteronism
2023
Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Min Guo | 374 | 133 | 114 | 143 | 46 | 833 | |
| Aruna Vashishta | 376 | 107 | 59 | 63 | 38 | 791 | |
| Tomoko Yamaguchi | 271 | 57 | 72 | 110 | 40 | 822 | |
| Yu Tian | 344 | 82 | 91 | 76 | 60 | 714 | |
| Yongjin Lee | 425 | 57 | 57 | 117 | 56 | 926 | |
| Yitong Zhao | 451 | 83 | 83 | 49 | 57 | 961 | |
| Xiaoling Guo | 412 | 112 | 86 | 62 | 64 | 977 | |
| Rong Zhang | 489 | 127 | 149 | 36 | 51 | 963 | |
| Yu Li | 373 | 82 | 54 | 49 | 47 | 826 | |
| Carla M. Wood | 343 | 44 | 85 | 108 | 36 | 795 | |
| Bingbing Chen | 209 | 37 | 89 | 109 | 47 | 779 |
All Works
Login with ORCID to disown or claim papers
Loading papers...